Clinical Pharmacology and Drug Toxicity — MCQs

A 55-year-old female with end-stage renal disease (ESRD) due to poorly controlled diabetes, who received a cadaveric kidney transplant, presented two weeks post-transplant with decreased urine output. Her blood pressure was 160/95 mm Hg. Examination revealed an enlarged and tender graft. Laboratory investigations showed a serum creatinine of 4 mg/dl. Considering transplant rejection and drug toxicity as differential diagnoses, which of the following immunosuppressive medications is most likely responsible for this clinical scenario?

Q87Medium

A 48-year-old male with a 15-year history of poorly controlled hypertension and type 2 diabetes mellitus presents with generalized facial and leg swelling and moderately increased albuminuria. Which of the following medications should not be prescribed to this patient?

Q88Easy

Rate of IV infusion of potassium in severe hypokalemia should not exceed?

Q89Medium

Which of the following drugs can cause altered taste sensation?

Q90Medium

All of the following statements about mycophenolate mofetil are true except?

Clinical Pharmacology and Drug Toxicity Indian Medical PG Practice Questions and MCQs

Question 81: All of the following drugs can produce hyperuricemia EXCEPT:

A. Ethambutol
B. Pyrazinamide
C. Sulfinpyrazone (Correct Answer)
D. Hydrochlorothiazide

Explanation: ### Explanation The correct answer is **Sulfinpyrazone**. **1. Why Sulfinpyrazone is the correct answer:** Hyperuricemia (elevated serum uric acid) occurs when drugs either increase uric acid production or, more commonly, decrease its renal excretion. **Sulfinpyrazone** is a **uricosuric agent** [1, 3]. It works by inhibiting the URAT1 transporter in the proximal convoluted tubule, thereby blocking the reabsorption of uric acid [1]. This increases the excretion of uric acid in the urine, effectively **lowering** serum uric acid levels [1]. Therefore, it is used to treat chronic gout, not cause hyperuricemia. **2. Why the other options are incorrect:** * **Pyrazinamide & Ethambutol (Options A & B):** These are first-line anti-tubercular drugs (ATT). Both inhibit the renal excretion of uric acid. Pyrazinamide is the most potent offender among ATT, often causing significant asymptomatic hyperuricemia [1]. * **Hydrochlorothiazide (Option D):** Thiazide and loop diuretics cause hyperuricemia by two mechanisms: (a) volume depletion leading to enhanced proximal tubular reabsorption of uric acid, and (b) competing with uric acid for the organic anion secretory transport system in the kidney. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Hyperuricemia (CANT LEAP):** **C**yclosporine, **A**lcohol, **N**iacin, **T**hiazides, **L**oop diuretics, **E**thambutol, **A**spirin (low dose), **P**yrazinamide. * **Aspirin Paradox:** Low-dose aspirin (<2g/day) causes uric acid retention (hyperuricemia), whereas high-dose aspirin (>5g/day) is uricosuric [1]. * **Drug of Choice:** Allopurinol (Xanthine Oxidase inhibitor) is the DOC for chronic gout [2, 3], but it should **never** be started during an acute attack as it may worsen the inflammation [2]. Allopurinol reduces total uric acid by inhibiting xanthine oxidase [2, 3].

Question 82: Which of the following is not a feature of organophosphorous poisoning?

A. Miosis
B. Increased salivation
C. Asthma
D. Tachycardia (Correct Answer)

Explanation: **Explanation:** Organophosphorous (OP) compounds act by irreversibly inhibiting the enzyme **Acetylcholinesterase (AChE)**. This leads to an accumulation of Acetylcholine (ACh) at both muscarinic and nicotinic receptors, resulting in a "cholinergic crisis." **Why Tachycardia is the Correct Answer:** The hallmark of OP poisoning is **parasympathetic overactivity** (muscarinic effects). The heart primarily responds to muscarinic stimulation (M2 receptors) with **Bradycardia**. While nicotinic stimulation at sympathetic ganglia can theoretically cause tachycardia, the dominant clinical presentation in OP poisoning is bradycardia. Therefore, tachycardia is considered an atypical feature rather than a classic one. **Analysis of Incorrect Options:** * **Miosis (A):** Stimulation of M3 receptors on the pupillary sphincter muscle causes pupillary constriction (pinpoint pupils). This is a classic diagnostic sign. * **Increased Salivation (B):** ACh stimulates exocrine glands via M3 receptors, leading to excessive salivation, lacrimation, and sweating (the "S" in SLUDGE syndrome). * **Asthma (C):** OP poisoning causes intense bronchoconstriction and increased bronchial secretions (bronchorrhea) via M3 receptors, mimicking an acute asthma exacerbation. **NEET-PG High-Yield Pearls:** 1. **Mnemonic for Muscarinic Effects:** **DUMBELS** (Diarrhea, Urination, Miosis, Bradycardia/Bronchospasm, Emesis, Lacrimation, Salivation). 2. **Nicotinic Effects:** Muscle fasciculations, cramping, and weakness (leading to respiratory failure). 3. **Treatment:** * **Atropine:** Specific physiological antidote (antagonizes muscarinic effects). Titrated until "Atropinization" (clear lungs and heart rate >80 bpm). * **Pralidoxime (PAM):** Enzyme reactivator (works on nicotinic receptors if given before "aging" of the enzyme). 4. **Cause of Death:** Usually respiratory failure due to bronchoconstriction, excessive secretions, and paralysis of the diaphragm.

Question 83: The preferred antidote for paracetamol (acetaminophen) poisoning is?

A. Activated charcoal
B. N-acetyl cysteine (Correct Answer)
C. Adrenaline
D. Magnesium hydroxide gel

Explanation: **Explanation:** **1. Mechanism of N-acetyl cysteine (NAC):** Paracetamol is primarily metabolized via glucuronidation and sulfation. A small portion is metabolized by **CYP2E1** into a highly reactive toxic metabolite called **NAPQI** (*N-acetyl-p-benzoquinone imine*). Normally, NAPQI is neutralized by **Glutathione**. In toxicity, glutathione stores are depleted, leading to NAPQI-induced hepatic necrosis. **N-acetyl cysteine (NAC)** is the specific antidote because it: * Acts as a precursor for glutathione synthesis. * Directly detoxifies NAPQI by acting as a glutathione substitute. * Is most effective when administered within **8–10 hours** of ingestion. **2. Analysis of Incorrect Options:** * **A. Activated charcoal:** While it can reduce drug absorption if given within 1–2 hours of ingestion, it is a general decontaminant, not a specific antidote. * **C. Adrenaline:** This is the drug of choice for anaphylactic shock; it has no role in paracetamol metabolism or hepatotoxicity. * **D. Magnesium hydroxide gel:** This is an antacid/osmotic laxative used for dyspepsia or constipation; it does not neutralize NAPQI. **3. High-Yield Clinical Pearls for NEET-PG:** * **Rumack-Matthew Nomogram:** Used to determine the need for NAC treatment based on plasma paracetamol levels vs. time since ingestion. * **Toxic Dose:** In adults, hepatotoxicity typically occurs at doses >7.5–10g. * **Clinical Stages:** Initial symptoms are non-specific (nausea/vomiting), but **hepatic transaminases (ALT/AST)** peak between 72–96 hours. * **Route:** NAC can be given IV or orally (though the oral form has a foul, "rotten egg" smell).

Question 84: Which drug is NOT contraindicated in pregnancy?

A. Propyl-thiouracil (Correct Answer)
B. Radioactive Iodine
C. Valproate
D. Warfarin

Explanation: The management of hyperthyroidism in pregnancy requires careful selection of antithyroid drugs. **Propylthiouracil (PTU)** is the drug of choice during the **first trimester** of pregnancy. It is highly protein-bound, which results in less placental transfer compared to Methimazole [1]. Furthermore, Methimazole is associated with fetal anomalies like *aplasia cutis* and *choanal atresia*, making PTU the safer alternative during early organogenesis [1]. **Analysis of Incorrect Options:** * **Radioactive Iodine (I-131):** Absolutely contraindicated. It crosses the placenta and can lead to permanent fetal thyroid ablation and subsequent cretinism [1]. * **Valproate:** A potent teratogen. It is associated with a high risk of **Neural Tube Defects (NTDs)**, specifically spina bifida, as well as "Fetal Valproate Syndrome" (craniofacial anomalies and developmental delay). * **Warfarin:** Crosses the placenta and causes **Fetal Warfarin Syndrome** (chondrodysplasia punctata, nasal hypoplasia, and CNS defects). Low Molecular Weight Heparin (LMWH) is the preferred anticoagulant in pregnancy as it does not cross the placenta. **High-Yield NEET-PG Pearls:** * **PTU vs. Methimazole:** PTU is preferred in the **1st trimester** (lower teratogenicity), while Methimazole is preferred in the **2nd and 3rd trimesters** (due to PTU’s risk of maternal hepatotoxicity) [1]. * **Drug of Choice for Hyperthyroid Crisis:** PTU is preferred because it also inhibits the peripheral conversion of T4 to T3. * **Safe Antiepileptics:** Levetiracetam and Lamotrigine are generally considered safer alternatives to Valproate during pregnancy.

Question 85: All of the following can cause Optic Neuritis, except:

A. Rifampicin (Correct Answer)
B. Digoxin
C. Chloroquine
D. Ethambutol

Explanation: **Explanation:** The correct answer is **Rifampicin**. While Rifampicin is a cornerstone of antitubercular therapy (ATT), its primary ocular side effect is the orange-red discoloration of tears and secretions. It does **not** typically cause optic neuritis. **Why the other options are incorrect:** * **Ethambutol:** This is the most classic cause of dose-dependent **retrobulbar optic neuritis** [1]. It typically presents as decreased visual acuity and loss of red-green color discrimination. Patients on Ethambutol require baseline and monthly visual acuity and color vision testing. * **Chloroquine (and Hydroxychloroquine):** These drugs are notorious for ocular toxicity. While they are most famous for causing **"Bull’s eye maculopathy"** due to melanin binding in the retinal pigment epithelium, they can also lead to optic nerve atrophy and neuritis in chronic high doses. * **Digoxin:** Digitalis toxicity frequently manifests with visual disturbances. While "Xanthopsia" (yellow-green halos) is most common, severe toxicity can lead to **optic neuritis** and blurred vision. **High-Yield Clinical Pearls for NEET-PG:** * **Ethambutol Toxicity:** It is contraindicated in children too young to undergo visual testing (usually <6 years). * **Isoniazid (INH):** Though not listed here, INH can also rarely cause optic neuritis (preventable with Pyridoxine). * **Amiodarone:** Another high-yield drug that causes both optic neuropathy and corneal microdeposits (vortex keratopathy). * **Sildenafil:** Associated with "Cyanopsia" (blue-tinted vision) and non-arteritic anterior ischemic optic neuropathy (NAION) [1]. * **Methanol:** A classic cause of sudden onset optic neuritis and permanent blindness.

Question 86: A 55-year-old female with end-stage renal disease (ESRD) due to poorly controlled diabetes, who received a cadaveric kidney transplant, presented two weeks post-transplant with decreased urine output. Her blood pressure was 160/95 mm Hg. Examination revealed an enlarged and tender graft. Laboratory investigations showed a serum creatinine of 4 mg/dl. Considering transplant rejection and drug toxicity as differential diagnoses, which of the following immunosuppressive medications is most likely responsible for this clinical scenario?

A. Azathioprine
B. Cyclosporine (Correct Answer)
C. Methylprednisolone
D. Anti-thymocyte globulin (ATG)

Explanation: Explanation: The clinical presentation of **decreased urine output, hypertension, a tender graft, and elevated creatinine** post-transplant creates a diagnostic dilemma between acute graft rejection and **calcineurin inhibitor (CNI) nephrotoxicity** [1, 2].Why Cyclosporine is the correct answer: Cyclosporine (and Tacrolimus) are potent immunosuppressants that cause **afferent arteriolar vasoconstriction**. This leads to decreased renal blood flow and a reduction in GFR. In the acute setting, this "functional" renal failure mimics rejection. However, the presence of **systemic hypertension** and the specific nephrotoxic profile of CNIs make Cyclosporine the most likely culprit among the choices [1, 2]. It is a classic "high-yield" side effect where the drug used to save the kidney actually damages it.Why other options are incorrect: Azathioprine: An antimetabolite (purine synthesis inhibitor). Its primary dose-limiting toxicity is **bone marrow suppression** (leukopenia), not nephrotoxicity.Methylprednisolone: A corticosteroid used to *treat* acute rejection. While it causes hypertension and hyperglycemia, it does not cause acute renal failure or graft tenderness.Anti-thymocyte globulin (ATG): Used for induction therapy or steroid-resistant rejection. Its main side effects are cytokine release syndrome (fever, chills) and serum sickness, not direct nephrotoxicity.NEET-PG High-Yield Pearls: **Cyclosporine vs. Tacrolimus:** Both cause nephrotoxicity and neurotoxicity. However, Cyclosporine is more associated with **gingival hyperplasia and hirsutism** [2], while Tacrolimus is more associated with **post-transplant diabetes mellitus (PTDM)** [1].Monitoring: Therapeutic Drug Monitoring (TDM) is mandatory for CNIs due to their narrow therapeutic index.Distinction: On biopsy, CNI toxicity shows isometric vacuolization of tubular cells, whereas rejection shows lymphocytic infiltration (tubulitis).

Question 87: A 48-year-old male with a 15-year history of poorly controlled hypertension and type 2 diabetes mellitus presents with generalized facial and leg swelling and moderately increased albuminuria. Which of the following medications should not be prescribed to this patient?

A. Dolutegravir
B. Lamivudine
C. Emtricitabine
D. Tenofovir (Correct Answer)

Explanation: ### **Explanation** **Correct Option: D. Tenofovir** The patient presents with long-standing hypertension and diabetes mellitus, complicated by generalized edema and albuminuria. This clinical picture is highly suggestive of **Diabetic Nephropathy** and chronic kidney disease (CKD). **Tenofovir Disoproxil Fumarate (TDF)** is a Nucleotide Reverse Transcriptase Inhibitor (NRTI) known for its potential **nephrotoxicity**. It is primarily excreted by the kidneys via glomerular filtration and active tubular secretion. TDF can cause proximal renal tubular dysfunction (Fanconi Syndrome) and a decline in the Glomerular Filtration Rate (GFR). In a patient with pre-existing renal compromise due to diabetes and hypertension, Tenofovir is contraindicated or requires extreme caution and dose adjustment. (Note: Tenofovir Alafenamide (TAF) is a newer prodrug with significantly lower renal toxicity). **Analysis of Incorrect Options:** * **A. Dolutegravir:** An Integrase Strand Transfer Inhibitor (INSTI). While it can cause a slight increase in serum creatinine by inhibiting the OCT2 transporter, it does not cause actual renal injury or affect GFR. * **B & C. Lamivudine and Emtricitabine:** These are NRTIs that are generally considered renal-safe. While they require dose adjustments in patients with low creatinine clearance, they are not inherently nephrotoxic and are not contraindicated in the same manner as Tenofovir. ### **High-Yield Clinical Pearls for NEET-PG:** 1. **Tenofovir Toxicity:** Classically presents as **Fanconi Syndrome** (proteinuria, glucosuria, phosphaturia, and metabolic acidosis). 2. **Drug of Choice:** In HIV patients with renal impairment, **Abacavir** is often preferred over Tenofovir (provided the patient is HLA-B*5701 negative). 3. **Monitoring:** Always check baseline Creatinine and Urine Protein before starting TDF-based regimens. 4. **Mnemonic:** "Tenofovir targets the Tubules" (Proximal Convoluted Tubule).

Question 88: Rate of IV infusion of potassium in severe hypokalemia should not exceed?

A. 20 mmol/hour (Correct Answer)
B. 40 mmol/hour
C. 60 mmol/hour
D. 80 mmol/hour

Explanation: **Explanation:** The management of severe hypokalemia requires cautious intravenous replacement to prevent life-threatening complications. The standard safety limit for the rate of IV potassium infusion is **20 mmol/hour**. **Why Option A is Correct:** Potassium is primarily an intracellular cation. Rapid infusion can lead to a transient but dangerous rise in extracellular (plasma) potassium levels before the ion can shift into the cells. Exceeding 20 mmol/hour significantly increases the risk of **iatrogenic hyperkalemia**, which can cause fatal cardiac arrhythmias or cardiac arrest. In most clinical settings, 10 mmol/hour is the routine rate, while 20 mmol/hour is reserved for severe, symptomatic cases under continuous ECG monitoring. **Why Other Options are Incorrect:** * **Options B, C, and D (40, 60, 80 mmol/hour):** These rates are excessively high and exceed the heart's threshold for electrical stability. Infusing potassium at these speeds can lead to immediate asystole or ventricular fibrillation. Such high concentrations are also highly irritating to peripheral veins, causing severe thrombophlebitis. **High-Yield Clinical Pearls for NEET-PG:** * **Monitoring:** Continuous ECG monitoring and hourly serum potassium checks are mandatory if the infusion rate exceeds 10 mmol/hour. * **Concentration:** For peripheral lines, the concentration should not exceed **40 mmol/L** to avoid phlebitis. Higher concentrations require a central venous catheter. * **The "Magnesium" Link:** If hypokalemia is refractory to treatment, always check **Magnesium levels**. Hypomagnesemia promotes renal potassium wasting; you cannot correct potassium until magnesium is replenished. * **Diluent:** Avoid using Dextrose-containing fluids for initial replacement, as insulin release triggered by glucose will shift potassium into cells, further worsening the hypokalemia.

Question 89: Which of the following drugs can cause altered taste sensation?

A. Pefloxacin
B. Rifampicin
C. Ciprofloxacin
D. Captopril (Correct Answer)

Explanation: **Explanation:** **Correct Option: D. Captopril** Captopril, an ACE inhibitor, is well-known for causing **dysgeusia** (altered taste sensation) or ageusia (loss of taste). This side effect is primarily attributed to the presence of a **sulfhydryl (-SH) group** in its chemical structure [1]. This group can interfere with zinc metabolism or directly affect taste bud function. While other ACE inhibitors can cause this, it is most frequently associated with Captopril [1]. **Analysis of Incorrect Options:** * **A & C (Pefloxacin and Ciprofloxacin):** These are Fluoroquinolones. Their primary side effects include GI upset, tendon rupture (Achilles tendon), and CNS stimulation. While some patients report a metallic taste with certain antibiotics (like Metronidazole or Clarithromycin), it is not a classic or high-yield side effect associated with Fluoroquinolones in the context of NEET-PG. * **B (Rifampicin):** The hallmark side effect of Rifampicin is the **orange-red discoloration** of body fluids (urine, sweat, tears). It is also a potent microsomal enzyme inducer and can cause hepatotoxicity, but it does not typically cause altered taste. **Clinical Pearls for NEET-PG:** * **ACE Inhibitor Side Effects (Mnemonic: CAPTOPRIL):** **C**ough (due to Bradykinin), **A**ngioedema, **P**roteinuria, **T**aste changes, **O**rthostatic hypotension, **P**regnancy contraindication, **R**enal artery stenosis (bilateral) contraindication, **I**ncreased Potassium (Hyperkalemia), **L**eukopenia. * **Other drugs causing metallic/altered taste:** Metronidazole, Lithium, Acetazolamide, Disulfiram, and Phenytoin. * **Zinc Deficiency:** Often presents with dysgeusia; Captopril-induced taste loss sometimes responds to zinc supplementation.

Question 90: All of the following statements about mycophenolate mofetil are true except?

A. It is a prodrug
B. Gastrointestinal toxicity is common
C. It is used in transplant recipients where other drugs are not effective
D. It is highly nephrotoxic (Correct Answer)

Explanation: ### Explanation **Mycophenolate Mofetil (MMF)** is a potent immunosuppressant widely used in organ transplantation and autoimmune disorders. **Why Option D is the Correct Answer (The "Except"):** Unlike Calcineurin inhibitors (CNIs) like **Cyclosporine** and **Tacrolimus**, Mycophenolate Mofetil is **not nephrotoxic**. In fact, it is often used as a "renal-sparing" agent to reduce the dose of CNIs in transplant patients to preserve kidney function. Its primary toxicities are hematological (bone marrow suppression) and gastrointestinal. **Analysis of Other Options:** * **Option A (Prodrug):** This is true. MMF is a prodrug that is rapidly hydrolyzed in the liver to its active metabolite, **Mycophenolic Acid (MPA)**. * **Option B (GI Toxicity):** This is true. Gastrointestinal side effects (nausea, vomiting, abdominal pain, and diarrhea) are the **most common** adverse effects, often requiring dose adjustments. * **Option C (Use in Transplant):** This is true. MMF is a cornerstone in preventing acute rejection in solid organ transplants (kidney, heart, liver), often used in combination with steroids and CNIs. **Mechanism of Action (High-Yield):** MMF acts by **non-competitive, reversible inhibition of Inosine Monophosphate Dehydrogenase (IMPDH)**. This enzyme is crucial for the *de novo* synthesis of guanosine nucleotides. Since T and B lymphocytes rely solely on the *de novo* pathway (lacking the salvage pathway), MMF selectively inhibits lymphocyte proliferation. **Clinical Pearls for NEET-PG:** 1. **Drug of choice:** MMF is the preferred drug for **Lupus Nephritis**. 2. **Teratogenicity:** It is highly teratogenic (Category D), associated with "Mycophenolate embryopathy" (ear and facial defects). 3. **Monitoring:** Unlike Tacrolimus, routine Therapeutic Drug Monitoring (TDM) is generally not mandatory for MMF.

Practice by Chapter

Principles of Clinical Pharmacology

Practice Questions

Therapeutic Drug Monitoring

Practice Questions

Drug Toxicity and Overdose

Practice Questions

Antidotes and Their Applications

Practice Questions

Management of Drug Poisoning

Practice Questions

Drug-Induced Liver Injury

Practice Questions

Drug-Induced Kidney Injury

Practice Questions

Drug-Induced Blood Dyscrasias

Practice Questions

Drug-Induced QT Prolongation

Practice Questions

Pharmacovigilance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free